Your browser doesn't support javascript.
loading
Re: Differential influence of vemurafenib and dabrafenib on patients' lymphocytes despite similar clinical efficacy in melanoma.
Diwakar, D; Choi, T; Tawbi, T H; Kirkwood, J M.
Afiliación
  • Diwakar D; Division of Hematology-Oncology, Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, USA.
  • Choi T; Division of Hematology-Oncology, Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, USA.
  • Tawbi TH; Division of Hematology-Oncology, Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, USA.
  • Kirkwood JM; Division of Hematology-Oncology, Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, USA kirkwoodjm@upmc.edu.
Ann Oncol ; 25(8): 1670-1, 2014 Aug.
Article en En | MEDLINE | ID: mdl-24890848
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Oximas / Sulfonamidas / Subgrupos Linfocitarios / Imidazoles / Indoles / Melanoma / Antineoplásicos Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2014 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Oximas / Sulfonamidas / Subgrupos Linfocitarios / Imidazoles / Indoles / Melanoma / Antineoplásicos Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2014 Tipo del documento: Article